ANAHEIM, CA, UNITED STATES, January 23, 2026 /EINPresswire.com/ — SK Labs, a contract manufacturer specializing in dietary supplement capsules, tablets, and powders, has earned NSF/ANSI 455-2 Good ...
The New Voice of Ukraine on MSN
Ukraine’s drug supply at risk as GMP delays stall imports during wartime shortages
Companies report that overly complex procedures for confirming compliance with Good Manufacturing Practices (GMP) are ...
As discussed in the Product Perspective, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents a major shift in cosmetic industry regulations. This article is one of a series of ...
The Dutch authority carrying out GMP inspections, the Health and Youth Care Inspectorate (IGJ), announced it will carry out a series of ...
Rockville-based biotech company Rise Therapeutics Wednesday announced it has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National ...
Manufacturers are usually subjected to a diverse variety of regulations typically established by international and regional bodies. Failure to comply can result in the loss of authorization and ...
EXPANSION ADDS STATE-OF-THE-ART UPSTREAM AND DOWNSTREAM GMP PROCESSING CAPABILITIES TO MEET THE GROWING DEMAND FOR 2,000 ...
ST. PETERSBURG, Fla., Jan. 7, 2026 /PRNewswire/ -- Health & Beauty Manufacturing (HBM), a U.S.-based contract manufacturer, today announced the formal introduction of its GMP-certified manufacturing ...
Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and ...
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. At ...
InstantGMP Named #1 for EBR, LIMS & MES Integration Being recognized by Root Analysis as the number one provider of ...
TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results